Lee Ming-Ching, Buitrago Daniel H, Kadota Kyuichi, Jones David R, Adusumilli Prasad S
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA ; Institute of Clinical Medicine, National Yang-Ming University, No.155, Sec.2, Linong Street, Taipei 112, Taiwan (ROC).
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Lung Cancer Manag. 2014 Jun 1;3(3):245-253. doi: 10.2217/lmt.14.15.
Micropapillary (MIP) histologic subtype included in the classification of lung adenocarcinomas (ADCs) is associated with both size- and stage-independent poor prognoses. MIP pattern in lung ADCs, even at small, early stages, correlates with high lymphovascular invasion, visceral pleural invasion and lymph node metastases. Recently, we reported that patients with a MIP component are at a higher risk of locoregional recurrence after limited resection. Identification of a MIP pattern is only possible with permanent pathologic sections; preoperative imaging, cytology or intraoperative frozen section specimens remain unreliable. The intermixed, heterogenous morphology of lung ADC presents a technical challenge in investigating the molecular biology of cells with MIP morphology. A comprehensive understanding of the biology of MIP morphology is vital for therapeutic interventions.
肺腺癌(ADC)分类中包含的微乳头(MIP)组织学亚型与大小和分期无关的不良预后相关。肺ADC中的MIP模式,即使在小的早期阶段,也与高淋巴血管侵犯、脏层胸膜侵犯和淋巴结转移相关。最近,我们报道了具有MIP成分的患者在有限切除后局部区域复发的风险更高。只有通过永久病理切片才能识别MIP模式;术前影像学、细胞学或术中冰冻切片标本仍然不可靠。肺ADC混合、异质的形态在研究具有MIP形态的细胞的分子生物学方面提出了技术挑战。全面了解MIP形态的生物学对于治疗干预至关重要。